Efficacy and Safety of Tx360® Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Migraine
Clinical trial NCT03337620 · COMPLETED
Trial details
- NCT number
- NCT03337620
- Sponsor
- Tian Medical Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-20
- Primary completion
- 2023-11-15
- Enrollment
- 174
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.